Michel Vellard

2.7k total citations · 1 hit paper
18 papers, 2.1k citations indexed

About

Michel Vellard is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Michel Vellard has authored 18 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Physiology and 5 papers in Epidemiology. Recurrent topics in Michel Vellard's work include Lysosomal Storage Disorders Research (6 papers), RNA and protein synthesis mechanisms (4 papers) and RNA Research and Splicing (4 papers). Michel Vellard is often cited by papers focused on Lysosomal Storage Disorders Research (6 papers), RNA and protein synthesis mechanisms (4 papers) and RNA Research and Splicing (4 papers). Michel Vellard collaborates with scholars based in United States, France and Italy. Michel Vellard's co-authors include David M. Sabatini, Diego L. Medina, Roberto Zoncu, Andrea Ballabio, Carmine Settembre, Mathieu Ferron, Valeria Facchinetti, Gérard Karsenty, Serkan Erdin and Tuong Huynh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Michel Vellard

18 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB

2012 1.5k citations Carmine Settembre, Roberto Zoncu et al. The EMBO Journal profile →

Peers

Countries citing papers authored by Michel Vellard

Since Specialization

Citations

This map shows the geographic impact of Michel Vellard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Vellard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Vellard more than expected).

Fields of papers citing papers by Michel Vellard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Vellard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Vellard. The network helps show where Michel Vellard may publish in the future.

Co-authorship network of co-authors of Michel Vellard

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Vellard. A scholar is included among the top collaborators of Michel Vellard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Vellard. Michel Vellard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Galactosialidosis: preclinical enzyme replacement therapy in a mouse model of the disease, a proof of concept 2020 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Huimin Hu, (unknown), Elida Gomero, Rosario Mosca, (unknown), (unknown), Sean P. Cullen, (unknown), Diantha van de Vlekkert, Ida Annunziata, Michel Vellard, Emil Kakkis, (unknown), Alessandra d’Azzo	12
2	Vestronidase alfa: Recombinant human β-glucuronidase as an enzyme replacement therapy for MPS VII 2020 ·Molecular Genetics and Metabolism ·(unknown), (unknown), (unknown), Sean P. Cullen, Michel Vellard, Jeffrey H. Grubb, Agnieszka Jurecka, William S. Sly, Emil Kakkis	23
3	Substantial deficiency of free sialic acid in muscles of patients with GNE myopathy and in a mouse model 2017 ·PLoS ONE ·Yiu-mo Chan, Paul P. Lee, (unknown), (unknown), (unknown), Alison Skrinar, Michel Vellard, Emil Kakkis	12
4	A novel method for the large-scale production of PG-CNP37, a C-type natriuretic peptide analogue 2012 ·Journal of Biotechnology ·Shinong Long, (unknown), Sean Bell, (unknown), (unknown), Michel Vellard	5
5	A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB breakdown → 2012 ·The EMBO Journal ·Carmine Settembre, Roberto Zoncu, Diego L. Medina, Francesco Vetrini, Serkan Erdin, (unknown), Tuong Huynh, Mathieu Ferron, Gérard Karsenty, Michel Vellard, Valeria Facchinetti, David M. Sabatini, Andrea Ballabio	1495
6	Enzyme Replacement in a Human Model of Mucopolysaccharidosis IVA In Vitro and Its Biodistribution in the Cartilage of Wild Type Mice 2010 ·PLoS ONE ·(unknown), Daniel Wendt, Chuck Hague, Terri Christianson, (unknown), Danielle Crippen, Emil Kakkis, Michel Vellard	53
7	The Expression of Soluble and Active RecombinantHaemophilus influenzaeIgA1 Protease inE. coli 2010 ·SHILAP Revista de lepidopterología ·Shinong Long, (unknown), Michel Vellard	5
8	Structural and Biochemical Characterization of the Therapeutic Anabaena variabilis Phenylalanine Ammonia Lyase 2008 ·Journal of Molecular Biology ·Lin Wang, Alejandra Gámez, Holly Archer, Enrique E. Abola, Christineh N. Sarkissian, Paul Fitzpatrick, Daniel Wendt, Yanhong Zhang, Michel Vellard, Joshua Bliesath, Sean Bell, Jeffrey F. Lemontt, Charles R. Scriver, Raymond C. Stevens	78
9	Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice 2006 ·Gene Therapy ·(unknown), (unknown), Pavel V. Belichenko, (unknown), (unknown), Michel Vellard, William C. Mobley, Emil Kakkis	71
10	Lipoprotein Receptor Binding, Cellular Uptake, and Lysosomal Delivery of Fusions between the Receptor-associated Protein (RAP) and α-l-Iduronidase or Acid α-Glucosidase 2004 ·Journal of Biological Chemistry ·William S. Prince, Lynn M. McCormick, (unknown), Paul Fitzpatrick, (unknown), (unknown), Vishwanath Koppaka, Terri Christianson, Michel Vellard, Nadine Pavloff, (unknown), Minmin Qin, (unknown), Guojun Bu, Todd C. Zankel	35
11	The enzyme as drug: application of enzymes as pharmaceuticals 2003 ·Current Opinion in Biotechnology ·Michel Vellard	201
12	A potential splicing factor is encoded by the opposite strand of the trans-spliced c-myb exon. 1992 ·Proceedings of the National Academy of Sciences ·Michel Vellard, Alain Sureau, J. Soret, C. Martinerie, Bernard Perbal	77
13	The PR264/c-myb connection: expression of a splicing factor modulated by a nuclear protooncogene. 1992 ·Proceedings of the National Academy of Sciences ·Alain Sureau, J. Soret, Michel Vellard, J Crochet, Bernard Perbal	22
14	C-myb proto-oncogene: evidence for intermolecular recombination of coding sequences. 1991 ·PubMed ·Michel Vellard, J. Soret, E. Viégas-Pèquignot, Francis Galibert, (unknown), Bernard Dutrillaux, Bernard Perbal	21
15	A novel type of RNA-binding protein is potentially encoded by the opposite strand of the trans-spliced c-myb coding exon. 1991 ·PubMed ·Michel Vellard, J. Soret, Alain Sureau, Bernard Perbal	6
16	Chromosomal reallocation of the chicken c‐myb locus and organization of 3′‐proximal coding exons 1990 ·FEBS Letters ·Johann Soret, Michel Vellard, E. Viégas-Pèquignot, Françoise Apiou, Bernard Dutrillaux, Bernard Perbal	8
17	Intermolecular recombination of the c-myb proto-oncogene coding sequences in chicken: clues for a mechanism. 1990 ·PubMed ·Bernard Perbal, Michel Vellard	6
18	Organization of 5′proximal c‐myb exons in chicken DNA Implications for c‐myb tissue‐specific transcription 1988 ·FEBS Letters ·Johann Soret, Michel Vellard, Cécile Martinerie, Bernard Perbal	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact